Contact aspiration is comparable to stent retriever (SR) as frontline thrombectomy for patients with acute ischaemic stroke resulting from large vessel occlusion (LVO), according to the ASTER* trial presented at the recent International Stroke Conference (ISC 2017) held in Texas, Houston, US.
The phosphodiesterase 3 inhibitor cilostazol may prevent secondary stroke in individuals with a recent history of ischaemic stroke. However, there was a higher incidence of myocardial infarction in this group, according to findings of the PICASSO* study presented at the International Stroke Conference 2017 (ISC 2017) in Houston, Texas, US.
Initiating statin therapy within 24 hours of hospitalization for an acute ischaemic stroke did not appear to affect patient disability at 90 days poststroke, according to findings of the ASSORT* trial presented at the International Stroke Conference 2017 (ISC 2017) in Houston, Texas, US.
Intensive (triple) antiplatelet therapy does not affect the recurrence of ischaemic stroke or transient ischaemic attack (TIA) compared with guideline standard-of-care antiplatelet therapy, but increases the risk of bleeding, according to interim data from the TARDIS* trial presented at the International Stroke Conference 2017 (ISC 2017) in Houston, Texas.
Resuming oral anticoagulation therapy after a lobar or nonlobar intracerebral haemorrhage (ICH) is associated with a lower risk of mortality and favourable functional outcome, according to results of a meta-analysis presented at the International Stroke Conference 2017 (ISC 2017) in Houston, Texas, US.
Individuals with cerebral venous thrombosis (CVT) have a lower likelihood of developing a pulmonary embolism compared with those with deep vein thrombosis (DVT), according to a study presented at the recent International Stroke Conference 2017 (ISC 2017) in Houston, Texas.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Pharmacist - Malaysia digital copy today!
Treatment with eluxadoline, a new oral medication, relieved two major symptoms of irritable bowel syndrome with diarrhoea (IBS-D) — abdominal pain and diarrhoea, according to a study based on two phase III randomized controlled trials. [N Engl J Med 2016;374:242-253]
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Individuals with type 2 diabetes (T2D) who initiate therapy with sodium glucose cotransporter-2 (SGLT-2) inhibitors have lower risks of all-cause death and cardiovascular (CV) outcomes, specifically myocardial infarction (MI) and stroke, compared with those who initiate other glucose-lowering therapies, according to results from the CVD-REAL* 2 study.